<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<bel:document
    xmlns:bel="http://resources.openbel.org/v2.0/lang/xml-schema/version_2.0/xbel"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://resources.openbel.org/v2.0/lang/xml-schema/version_2.0 xbel.xsd">
    <bel:header>
        <bel:name>XBEL v2 Example</bel:name>
        <bel:description>XBEL v2 example document</bel:description>
        <bel:version>2016-06-08</bel:version>
        <bel:belVersion>2.0</bel:belVersion>
        <bel:copyright>Copyright (c) 2011-2015, Selventa. All Rights Reserved.</bel:copyright>
        <bel:contactInfo>support@belframework.org</bel:contactInfo>
        <bel:authorGroup>
            <bel:author>Selventa</bel:author>
        </bel:authorGroup>
        <bel:licenseGroup>
            <bel:license>Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License</bel:license>
        </bel:licenseGroup>
    </bel:header>
    <bel:namespaceGroup>
        <bel:namespace bel:prefix="CHEBI"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/chebi.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="CHEBIID"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/chebi-ids.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="EGID"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/entrez-gene-ids.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="GOBP"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/go-biological-process.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="HGNC"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/hgnc-human-genes.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="MESHCS"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/mesh-cellular-structures.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="MESHD"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/mesh-diseases.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="MESHPP"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/mesh-processes.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="MGI"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/mgi-mouse-genes.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="RGD"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/rgd-rat-genes.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="SCHEM"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-chemicals.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="SCOMP"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/selventa-named-complexes.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="SDIS"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/selventa-legacy-diseases.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="SFAM"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/selventa-protein-families.belns</bel:url></bel:resource></bel:namespace>
        <bel:namespace bel:prefix="SPID"><bel:resource><bel:url>http://resource.belframework.org/belframework/20150611/namespace/swissprot-ids.belns</bel:url></bel:resource></bel:namespace>
    </bel:namespaceGroup>
    <bel:annotationDefinitionGroup>
        <bel:internalAnnotationDefinition bel:id="TextLocation">
            <bel:description></bel:description>
            <bel:usage></bel:usage>
            <bel:listAnnotation>
                <bel:listValue>Abstract</bel:listValue>
                <bel:listValue>Results</bel:listValue>
                <bel:listValue>Legend</bel:listValue>
                <bel:listValue>Review</bel:listValue>
            </bel:listAnnotation>
        </bel:internalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="Anatomy">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/anatomy.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="Cell">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/cell.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="CellLine">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/cell-line.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="CellStructure">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/cell-structure.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="Disease">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/disease.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="MeSHAnatomy">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/mesh-anatomy.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
        <bel:externalAnnotationDefinition bel:id="Species">
            <bel:resource>
                <bel:url>
                    http://resource.belframework.org/belframework/20150611/annotation/species-taxonomy-id.belanno
                </bel:url>
            </bel:resource>
        </bel:externalAnnotationDefinition>
    </bel:annotationDefinitionGroup>
    <bel:statementGroup>
        <bel:name>"Group 1"</bel:name>
        <bel:statement bel:relationship="positiveCorrelation">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Oxidation and nitration of macromolecules, such as proteins, DNA and lipids, are prominent
in atherosclerotic arteries.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="pathology">
                    <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">lipid oxidation</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="positiveCorrelation">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Oxidation and nitration of macromolecules, such as proteins, DNA and lipids, are prominent
in atherosclerotic arteries.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="pathology">
                    <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">protein oxidation</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Arterial cells are highly susceptible to oxidative stress, which can induce both necrosis
and apoptosis (programmed cell death) [1,2]</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">response to oxidative stress</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Arterial cells are highly susceptible to oxidative stress, which can induce both necrosis
and apoptosis (programmed cell death) [1,2]</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">response to oxidative stress</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">necrosis</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>One such risk factor is oxLDL, which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in cultured cells and
in arteries [19–26]. Increased formation of oxygen radicals (and other radical
species) facilitates LDL oxidation and influences oxidation-sensitive mechanisms
[15].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>One such risk factor is oxLDL, which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in cultured cells and
in arteries [19–26]. Increased formation of oxygen radicals (and other radical
species) facilitates LDL oxidation and influences oxidation-sensitive mechanisms
[15].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>One such risk factor is oxLDL, which exert pro-apoptotic effects on a variety of cell
lineages, including endothelial cells and VSMCs, both in cultured cells and
in arteries [19–26]. Increased formation of oxygen radicals (and other radical
species) facilitates LDL oxidation and influences oxidation-sensitive mechanisms
[15].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">oxygen radical</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Not surprisingly, high concentrations of exogenous reactive oxygen species (ROS),
generated by enzymatic reactions or by radiation, also stimulate the apoptosis
of endothelial cells in vitro [29–31].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">reactive oxygen species</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>The peptide hormone angiotensin II and pro-inflammatory cytokines also trigger the
apoptotic program in endothelial cells [33,34].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">angiotensin II</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="positiveCorrelation">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Aging, one of the major predictors for atherosclerotic lesion formation, increases
the sensitivity of endothelial cells to apoptosis induced by in vitro and in vivo
stimuli [35–37].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">aging</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="pathology">
                    <bel:parameter bel:ns="MESHD">Plaque, Atherosclerotic</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Aging, one of the major predictors for atherosclerotic lesion formation, increases
the sensitivity of endothelial cells to apoptosis induced by in vitro and in vivo
stimuli [35–37].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">aging</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Shear stress enhances expression of the gene encoding the endothelial nitric oxide
synthase (eNOS) and further stimulates its enzymatic activity, leading to physiologic
low concentrations of nitric oxide (NO) within endothelial cells [44–46].
This continuous generation of NO prevents the apoptosis of endothelial cells,
thereby protecting the endothelial monolayer from injury [47,48].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">response to fluid shear stress</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="rnaAbundance">
                    <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Shear stress enhances expression of the gene encoding the endothelial nitric oxide
synthase (eNOS) and further stimulates its enzymatic activity, leading to physiologic
low concentrations of nitric oxide (NO) within endothelial cells [44–46].
This continuous generation of NO prevents the apoptosis of endothelial cells,
thereby protecting the endothelial monolayer from injury [47,48].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">response to fluid shear stress</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="directlyIncreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Shear stress enhances expression of the gene encoding the endothelial nitric oxide
synthase (eNOS) and further stimulates its enzymatic activity, leading to physiologic
low concentrations of nitric oxide (NO) within endothelial cells [44–46].
This continuous generation of NO prevents the apoptosis of endothelial cells,
thereby protecting the endothelial monolayer from injury [47,48].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">NOS3</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">nitric oxide</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Shear stress enhances expression of the gene encoding the endothelial nitric oxide
synthase (eNOS) and further stimulates its enzymatic activity, leading to physiologic
low concentrations of nitric oxide (NO) within endothelial cells [44–46].
This continuous generation of NO prevents the apoptosis of endothelial cells,
thereby protecting the endothelial monolayer from injury [47,48].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">nitric oxide</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">artery</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>More importantly, intervention with L-arginine has induced beneficial effects on atherosclerosis
in experimental and human studies [46,49].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">L-arginine</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="pathology">
                    <bel:parameter bel:ns="MESHD">Atherosclerosis</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>OxLDL induces the generation of ROS in different vascular cell types [15,58], and
might also promote a rise in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant enzymes Cu/Zn superoxide dismutase
[59] and glutathione peroxidase [60].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">reactive oxygen species</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>OxLDL induces the generation of ROS in different vascular cell types [15,58], and
might also promote a rise in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant enzymes Cu/Zn superoxide dismutase
[59] and glutathione peroxidase [60].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="HGNC">SOD1</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>OxLDL induces the generation of ROS in different vascular cell types [15,58], and
might also promote a rise in ROS levels through a decrease in ROS degradation,
because oxLDL induces a reduction in the antioxidant enzymes Cu/Zn superoxide dismutase
[59] and glutathione peroxidase [60].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">Oxidized Low Density Lipoprotein</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="SFAM">GPX Family</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>For instance, during 7-ketocholesterol-induced apoptosis of U937 cells, the cellular
antioxidant content falls rapidly [64], but administration of two potent antioxidants,
the aminothiols glutathione and N-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death [64].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="negativeCorrelation">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>For instance, during 7-ketocholesterol-induced apoptosis of U937 cells, the cellular
antioxidant content falls rapidly [64], but administration of two potent antioxidants,
the aminothiols glutathione and N-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death [64].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">antioxidant</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>For instance, during 7-ketocholesterol-induced apoptosis of U937 cells, the cellular
antioxidant content falls rapidly [64], but administration of two potent antioxidants,
the aminothiols glutathione and N-acetylcysteine, can protect themonocytic
cells from 7-ketocholesterol-induced apoptotic cell death [64].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">antioxidant</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:statement bel:relationship="increases">
                    <bel:subject>
                        <bel:term bel:function="abundance">
                            <bel:parameter bel:ns="SCHEM">7-Ketocholesterol</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="biologicalProcess">
                            <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>In addition, another oxygen-radical scavenger enzyme, catalase, can prevent VSMC apoptosis
triggered by hydrogen peroxide [27,65].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">hydrogen peroxide</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>In addition, another oxygen-radical scavenger enzyme, catalase, can prevent VSMC apoptosis
triggered by hydrogen peroxide [27,65].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="HGNC">CAT</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:statement bel:relationship="increases">
                    <bel:subject>
                        <bel:term bel:function="abundance">
                            <bel:parameter bel:ns="CHEBI">hydrogen peroxide</bel:parameter>
                        </bel:term>
                    </bel:subject>
                    <bel:object>
                        <bel:term bel:function="biologicalProcess">
                            <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                        </bel:term>
                    </bel:object>
                </bel:statement>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>The proto-oncogene c-myc can promote cell death (probably mediated through p53) or
cell proliferation, depending on its expression level. It functions as a nuclear
phosphoprotein with particular properties of a transcription factor [68,69].
In serum deprived cultures, cells overexpressing c-myc readily undergo apoptosis.
In addition, deregulation of c-myc causes apoptosis of VSMCs deprived of growth
factors or treated with cytokines such as interferon-g [70].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="HGNC">MYC</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>The proto-oncogene c-myc can promote cell death (probably mediated through p53) or
cell proliferation, depending on its expression level. It functions as a nuclear
phosphoprotein with particular properties of a transcription factor [68,69].
In serum deprived cultures, cells overexpressing c-myc readily undergo apoptosis.
In addition, deregulation of c-myc causes apoptosis of VSMCs deprived of growth
factors or treated with cytokines such as interferon-g [70].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="HGNC">MYC</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">cell proliferation</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="directlyIncreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Tissue factor (TF) is a 47 kDa transmembrane glycoprotein that initiates blood coagulation
by binding coagulation factor VII and its activated form (factor VIIa),
to produce a high-affinity complex [72] that proteolytically activates factors
IX and X, leading to thrombin generation.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="activity">
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F7</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F9</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="directlyIncreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Tissue factor (TF) is a 47 kDa transmembrane glycoprotein that initiates blood coagulation
by binding coagulation factor VII and its activated form (factor VIIa),
to produce a high-affinity complex [72] that proteolytically activates factors
IX and X, leading to thrombin generation.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="activity">
                    <bel:term bel:function="complexAbundance">
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                        </bel:term>
                        <bel:term bel:function="proteinAbundance">
                            <bel:parameter bel:ns="HGNC">F7</bel:parameter>
                        </bel:term>
                    </bel:term>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F10</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Tissue factor (TF) is a 47 kDa transmembrane glycoprotein that initiates blood coagulation
by binding coagulation factor VII and its activated form (factor VIIa),
to produce a high-affinity complex [72] that proteolytically activates factors
IX and X, leading to thrombin generation.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F9</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F2</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>Tissue factor (TF) is a 47 kDa transmembrane glycoprotein that initiates blood coagulation
by binding coagulation factor VII and its activated form (factor VIIa),
to produce a high-affinity complex [72] that proteolytically activates factors
IX and X, leading to thrombin generation.</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F10</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F2</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:annotation bel:refID="CellStructure">Cell Membrane</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>TF works at the surface of cell membranes, and its activity is highly dependent on
the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed
on the cell surface during apoptotic death and confers a potent pro-coagulant
activity to the apoptotic cell [74].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="activity">
                    <bel:term bel:function="proteinAbundance">
                        <bel:parameter bel:ns="HGNC">F3</bel:parameter>
                    </bel:term>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:annotation bel:refID="CellStructure">Cell Membrane</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>TF works at the surface of cell membranes, and its activity is highly dependent on
the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed
on the cell surface during apoptotic death and confers a potent pro-coagulant
activity to the apoptotic cell [74].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">apoptotic process</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="increases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:annotation bel:refID="CellStructure">Cell Membrane</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>TF works at the surface of cell membranes, and its activity is highly dependent on
the presence of phosphatidylserine (PS), an anionic phospholipid that is redistributed
on the cell surface during apoptotic death and confers a potent pro-coagulant
activity to the apoptotic cell [74].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="abundance">
                    <bel:parameter bel:ns="CHEBI">phosphatidyl-L-serine</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">coagulation</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
        <bel:statement bel:relationship="decreases">
            <bel:annotationGroup>
                <bel:annotation bel:refID="Disease">atherosclerosis</bel:annotation>
                <bel:annotation bel:refID="Anatomy">cardiovascular system endothelium</bel:annotation>
                <bel:annotation bel:refID="TextLocation">Review</bel:annotation>
                <bel:annotation bel:refID="Cell">endothelial cell</bel:annotation>
                <bel:annotation bel:refID="MeSHAnatomy">Muscle, Smooth, Vascular</bel:annotation>
                <bel:annotation bel:refID="CellLine">U-937 cell</bel:annotation>
                <bel:annotation bel:refID="CellStructure">Cell Membrane</bel:annotation>
                <bel:citation bel:type="PubMed">
                    <bel:reference>12928037</bel:reference>
                    <bel:name>Trends in molecular medicine</bel:name>
                    <bel:comment></bel:comment>
                    <bel:authorGroup>
                        <bel:author>de Nigris F</bel:author>
                        <bel:author>Lerman A</bel:author>
                        <bel:author>Ignarro LJ</bel:author>
                        <bel:author>Williams-Ignarro S</bel:author>
                        <bel:author>Sica V</bel:author>
                        <bel:author>Baker AH</bel:author>
                        <bel:author>Lerman LO</bel:author>
                        <bel:author>Geng YJ</bel:author>
                        <bel:author>Napoli C</bel:author>
                    </bel:authorGroup>
                </bel:citation>
                <bel:support>TIMP-3 can be anti-angiogenic by direct binding to vascular endothelial growth factor
(VEGF) receptor 2 in a matrix-metalloproteinase- independent manner [94].</bel:support>
            </bel:annotationGroup>
            <bel:subject>
                <bel:term bel:function="proteinAbundance">
                    <bel:parameter bel:ns="HGNC">TIMP3</bel:parameter>
                </bel:term>
            </bel:subject>
            <bel:object>
                <bel:term bel:function="biologicalProcess">
                    <bel:parameter bel:ns="GOBP">angiogenesis</bel:parameter>
                </bel:term>
            </bel:object>
        </bel:statement>
    </bel:statementGroup>
</bel:document>
